Sheng-Biao Wan (Shengbiao Wan)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

High Throughput

Anti Inflammatory

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Dongdong Luo, Xiaochun Liu, Leilei Jiang, Zhikun Guo, Yan Lv, Xiaochen Tian, Xiaoyan Wang, Shuxiang Cui, Sheng-Biao Wan, Ximing Xu, Xiaoyang Li, Xianjun Qu
Correction to "Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer". Journal of medicinal chemistry 65 (23) (2022)
Dongdong Luo, Xiaochun Liu, Leilei Jiang, Zhikun Guo, Yan Lv, Xiaochen Tian, Xiaoyan Wang, Shuxiang Cui, Sheng-Biao Wan, Xianjun Qu, Ximing Xu, Xiaoyang Li
Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer. Journal of medicinal chemistry 65 (21) (2022)
Yu-Hang Zhang, Wen-Na Shi, Shu-Hua Wu, Rong-Rong Miao, Shi-Yue Sun, Dong-Dong Luo, Sheng-Biao Wan, Zhi-Kun Guo, Wen-Yu Wang, Xin-Feng Yu, Shu-Xiang Cui, Xian-Jun Qu
SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression. Oncogene 39 (29) (2020)